Back
Cytokinetics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
45
CYTK
Cytokinetics
Last Price:
64.35
Seasonality Move:
12.64%
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
215.99
Seasonality Move:
-4.02%
Sell
45
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $63.37. The Score for CYTK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $210.08. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $63.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $210.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2 | Sell |
Relative Strength Index (14 RSI): | 39.34 | Sell |
Chaikin Money Flow: | 446915 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.12 - 72.68) | Sell |
Bollinger Bands (100): | (55.2 - 85.66) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.96 | Sell |
Relative Strength Index (14 RSI): | 41.16 | Sell |
Chaikin Money Flow: | 3368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (209.12 - 250.62) | Sell |
Bollinger Bands (100): | (212.99 - 251.91) | Sell |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.51 | Sell |
20-day SMA: | 68.3 | Sell |
50-day SMA: | 69.18 | Sell |
200-day SMA: | 51.66 | Buy |
8-day EMA: | 64.44 | Sell |
20-day EMA: | 66.78 | Sell |
50-day EMA: | 68.53 | Sell |
200-day EMA: | 57.55 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 204.94 | Buy |
20-day SMA: | 223.79 | Sell |
50-day SMA: | 240.98 | Sell |
200-day SMA: | 201.27 | Buy |
8-day EMA: | 207.54 | Buy |
20-day EMA: | 219.87 | Sell |
50-day EMA: | 229.81 | Sell |
200-day EMA: | 215.91 | Sell |
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.71 per share, a decrease this year of $4.24 per share, and an increase next year of $8.97 per share.
Cytokinetics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |